News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation
Photo from Emanuele Ammatuna/LinkedIn
Nov 4, 2023, 00:28

Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation

Emanuele Ammatuna, Hematologist at University Medical Center Groningen, shared on LinkedIn:

“Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation. The addition of a bcl-2 inhibitor to HMA should be the next investigation in this category of patients.”

Source: Emanuele Ammatuna/LinkedIn

bcl-2 inhibitor cancer decitabine Emanuele Ammatuna OncoDaily Oncology Stem Cell Transplantation
Blog
Jul 5, 2024, 04:34
Over $115,000 for neuroendocrine cancer research - Neuroendocrine Tumor Research Foundation
Blog
Jul 5, 2024, 03:56
Anirban Maitra: For computational Pathology aficionados resource paper from NCI PDXNet
Insight
Jul 5, 2024, 03:00
EClinicalMedicine has highlighted the SIOP Europe Annual Meeting 2024 in Milan
Blog
Jul 5, 2024, 02:55
Funds generated from the Lenox Hill Hospital gala will support several of the Brain Tumor Center’s initiatives - Northwell Cancer Institute
Drugs
Jul 5, 2024, 02:47
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Blog
Jul 5, 2024, 02:41
Nikolas Naleid: The use of ctDNA following locoregional therapy for oligometastatic CRC
Blog
Jul 5, 2024, 02:38
NCI Division of Cancer Prevention - Early Career Scientist Seminar with Dr. Venkateshwar Madka
Blog
Jul 5, 2024, 02:36
Dr. Girish Chinnaswamy has been elected Vice-Chair of the SIOP PARC Programme
Blog
Jul 5, 2024, 02:36
Moffitt Cancer Center announces the latest Research Instructor Designations
Blog
Jul 5, 2024, 02:31
EACR at the FEBS2024 Congress
Drugs
Jul 5, 2024, 02:30
Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma - ESMO
Blog
Jul 5, 2024, 02:27
ESMO - Ipilimumab and nivolumab in unresected advanced Hepatocellular Carcinoma